{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:29:47Z","timestamp":1787585387705,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018607","name":"Henan Province Science and Technology Innovation Talent Program","doi-asserted-by":"publisher","award":["LHGJ 20210296"],"award-info":[{"award-number":["LHGJ 20210296"]}],"id":[{"id":"10.13039\/501100018607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101491"],"award-info":[{"award-number":["82101491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782273"],"award-info":[{"award-number":["2025M782273"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbd.2026.107514","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T14:21:53Z","timestamp":1782656513000},"page":"107514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PPAR\u03b4 in neurological diseases: Mechanisms and therapeutic prospects"],"prefix":"10.1016","volume":"227","author":[{"given":"Yixuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mibo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107514_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuint.2018.09.006","article-title":"The PPAR\u03b4 agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17\/Treg-related signaling in the BTBR autistic mouse model","volume":"120","author":"Ahmad","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2026.107514_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.freeradbiomed.2025.11.040","article-title":"APOE4 impairs Nrf2-PINK1\/Parkin-dependent mitochondrial clearance through disrupted antioxidant and mitophagy signaling","volume":"243","author":"Akhter","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2026.107514_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.intimp.2019.01.057","article-title":"PPAR-\u03b4 and erucic acid in multiple sclerosis and Alzheimer\u2019s disease. Likely benefits in terms of immunity and metabolism","volume":"69","author":"Altinoz","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-019-00500-6","article-title":"Erucic acid, a nutritional PPAR\u03b4-ligand may influence Huntington\u2019s disease pathogenesis","volume":"35","author":"Altinoz","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.nbd.2026.107514_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100871","article-title":"PPAR\u03b4 and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson\u2019s disease","volume":"78","author":"Altinoz","year":"2021","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11011-016-9800-7","article-title":"PPAR\u03b4 agonist GW0742 ameliorates A\u03b21-42-induced hippocampal neurotoxicity in mice","volume":"31","author":"An","year":"2016","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40659-023-00438-1","article-title":"Neuroprotective effects of the PPAR\u03b2\/\u03b4 antagonist GSK0660 in in vitro and in vivo Parkinson\u2019s disease models","volume":"56","author":"Antonosante","year":"2023","journal-title":"Biol. Res."},{"key":"10.1016\/j.nbd.2026.107514_bb0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2018.12.001","article-title":"Promising neuroprotective effects of \u03b2-caryophyllene against LPS-induced oligodendrocyte toxicity: a mechanistic study","volume":"159","author":"Askari","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1172\/JCI27955","article-title":"PPAR delta: a dagger in the heart of the metabolic syndrome","volume":"116","author":"Barish","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0050","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41467-023-38233-x","article-title":"PPAR-\u03b3 regulates the effector function of human T helper 9 cells by promoting glycolysis","volume":"14","author":"Bertschi","year":"2023","journal-title":"Nat. Commun."},{"issue":"2\u20135","key":"10.1016\/j.nbd.2026.107514_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0960-0760(03)00214-0","article-title":"Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation","volume":"85","author":"Blanquart","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107514_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/WCO.0000000000001164","article-title":"Abnormal energy metabolism in ALS: a key player?","volume":"36","author":"Burg","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2026.107514_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418777329","article-title":"In vivo optical imaging of myelination events in a myelin basic protein promoter-driven luciferase transgenic mouse model","volume":"10","author":"Cao","year":"2018","journal-title":"ASN Neuro"},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3233\/JAD-190864","article-title":"An exploratory phase IIa study of the PPAR delta\/gamma agonist T3D-959 assessing metabolic and cognitive function in subjects with mild to moderate Alzheimer\u2019s disease","volume":"73","author":"Chamberlain","year":"2020","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"11","key":"10.1016\/j.nbd.2026.107514_bb0075","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/hmg\/ddw095","article-title":"Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington\u2019s disease","volume":"25","author":"Chandra","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0080","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00586.2014","article-title":"Inactivation of PPAR\u03b2\/\u03b4 adversely affects satellite cells and reduces postnatal myogenesis","volume":"309","author":"Chandrashekar","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.nbd.2026.107514_bb0085","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.021","article-title":"Activation of peroxisome proliferator-activated receptor \u03b2\/\u03b4 attenuates acute ischemic stroke on middle cerebral ischemia occlusion in rats","volume":"23","author":"Chao","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.nbd.2026.107514_bb0090","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbr.2018.06.005","article-title":"PPAR\u00df\/\u03b4 agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson\u2019s disease","volume":"356","author":"Chen","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"20","key":"10.1016\/j.nbd.2026.107514_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107514_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0105","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses","volume":"164","author":"Clark","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/md21020089","article-title":"Marine natural and nature-inspired compounds targeting peroxisome proliferator activated receptors (PPARs)","volume":"21","author":"D\u2019Aniello","year":"2023","journal-title":"Mar. Drugs"},{"issue":"17","key":"10.1016\/j.nbd.2026.107514_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172635","article-title":"Treatment of VLCAD-deficient patient fibroblasts with peroxisome proliferator-activated receptor \u03b4 agonist improves cellular bioenergetics","volume":"11","author":"D\u2019Annibale","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-160656","article-title":"Improved brain insulin\/IGF signaling and reduced neuroinflammation with T3D-959 in an experimental model of sporadic Alzheimer\u2019s disease","volume":"55","author":"de la Monte","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"5","key":"10.1016\/j.nbd.2026.107514_bb0125","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/jcp.25509","article-title":"Uric acid amplifies a\u03b2 amyloid effects involved in the cognitive dysfunction\/dementia: evidences from an experimental model in vitro","volume":"232","author":"Desideri","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"419","key":"10.1016\/j.nbd.2026.107514_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2332","article-title":"PPAR\u03b4 activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis","volume":"9","author":"Dickey","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.nbd.2026.107514_bb0135","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107514_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1570159X19666211109141330","article-title":"Advances in PPARs molecular dynamics and glitazones as a repurposing therapeutic strategy through mitochondrial redox dynamics against neurodegeneration","volume":"20","author":"Durai","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2026.107514_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.902047","article-title":"Peroxisomal proliferator-activated receptor \u03b2\/\u03b4 deficiency induces cognitive alterations","volume":"13","author":"Espinosa-Jim\u00e9nez","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107514_bb0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nm1025","article-title":"PPARs and the complex journey to obesity","volume":"10","author":"Evans","year":"2004","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020426","article-title":"Exploiting the therapeutic potential of endogenous immunomodulatory Systems in Multiple Sclerosis-Special Focus on the peroxisome proliferator-activated receptors (PPARs) and the kynurenines","volume":"20","author":"Fakan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.nbd.2026.107514_bb0165","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcb.25041","article-title":"PPAR\u03b2\/\u03b4 and \u03b3 in a rat model of Parkinson\u2019s disease: possible involvement in PD symptoms","volume":"116","author":"Falcone","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.nbd.2026.107514_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neuropharm.2018.08.003","article-title":"Role of PPAR-\u03b2\/\u03b4\/miR-17\/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats","volume":"140","author":"Gamdzyk","year":"2018","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.nbd.2026.107514_bb0180","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1111\/jcmm.15698","article-title":"GW0742 activates miR-17-5p and inhibits TXNIP\/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells","volume":"24","author":"Gamdzyk","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0185","article-title":"ATGL-mediated lipolysis is essential for myocellular mitochondrial function, mitochondria-lipid droplet interaction and mitochondrial network connectivity","volume":"1871","author":"Gemmink","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.nbd.2026.107514_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108226","article-title":"Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics","volume":"156","author":"Ghannam","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/apt.17046","article-title":"Review article: vascular effects of PPARs in the context of NASH","volume":"56","author":"Guix\u00e9-Muntet","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.nbd.2026.107514_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2025.106044","article-title":"Integration analysis of transcriptomics and proteomics reveals molecular pathways of duck intestinal epithelial cells in response to oxidative stress","volume":"104","author":"He","year":"2025","journal-title":"Poult. Sci."},{"key":"10.1016\/j.nbd.2026.107514_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"49","key":"10.1016\/j.nbd.2026.107514_bb0210","doi-asserted-by":"crossref","first-page":"35152","DOI":"10.1074\/jbc.274.49.35152","article-title":"Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor alpha. Importance of alpha-helical structure in the transactivating function","volume":"274","author":"Hi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0215","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mce.2011.07.017","article-title":"Structural and functional analysis of domains of the progesterone receptor","volume":"348","author":"Hill","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/HEP.0000000000000395","article-title":"Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study","volume":"78","author":"Hirschfield","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.nbd.2026.107514_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopha.2014.12.031","article-title":"PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects","volume":"70","author":"Huang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv083","article-title":"Hippocampal PPAR\u03b4 overexpression or activation represses stress-induced depressive behaviors and enhances neurogenesis","volume":"19","author":"Ji","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9500","key":"10.1016\/j.nbd.2026.107514_bb0235","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.nbd.2026.107514_bb0240","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.7150\/thno.96707","article-title":"Highly potent and selective PPAR\u03b4 agonist reverses memory deficits in mouse models of Alzheimer\u2019s disease","volume":"14","author":"Kim","year":"2024","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.nbd.2026.107514_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70651","article-title":"Netrin-1 inhibits neuroinflammation by modulating DRD2\/GSK3\u03b2 signaling and suppressing ROS in a Parkinson\u2019s disease model","volume":"31","author":"Kim","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0250","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0271678X17743876","article-title":"Oral administration of a novel lipophilic PPAR\u03b4 agonist is not neuroprotective after rodent cerebral ischemia","volume":"38","author":"Knauss","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/glia.23534","article-title":"PPAR\u03b2\/\u03b4-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1\u0394E9 astrocytes","volume":"67","author":"Konttinen","year":"2019","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.nbd.2026.107514_bb0260","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","article-title":"Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"issue":"7","key":"10.1016\/j.nbd.2026.107514_bb0265","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1002\/jcb.26732","article-title":"Activation of PPAR\u03b4 attenuates neurotoxicity by inhibiting lipopolysaccharide-triggered glutamate release in BV-2 microglial cells","volume":"119","author":"Lee","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.nbd.2026.107514_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050810","article-title":"PPAR\u03b4 activation mitigates 6-OHDA-induced neuronal damage by regulating intracellular iron levels","volume":"11","author":"Lee","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.nbd.2026.107514_bb0280","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.nbd.2026.107514_bb0285","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/leu.2016.395","article-title":"PPAR-delta promotes survival of chronic lymphocytic leukemia cells in energetically unfavorable conditions","volume":"31","author":"Li","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.nbd.2026.107514_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108685","article-title":"Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPAR\u03b3-dependent activation of PGC-1\u03b1\/GLUT4 signalling in APP\/PS1 transgenic mice","volume":"196","author":"Li","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2026.107514_bb0295","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2147\/DDDT.S257333","article-title":"Melatonin alleviates neuronal damage after intracerebral hemorrhage in hyperglycemic rats","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.nbd.2026.107514_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1695992","article-title":"Recent advances in understanding oxidative stress in sepsis: pathogenic roles and antioxidant therapeutic prospects - a narrative review","volume":"16","author":"Lin","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2026.107514_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114615","article-title":"GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR(\u03b2\/\u03b4)\/CD300a\/SHP1 pathway after GMH in neonatal rats","volume":"372","author":"Lu","year":"2024","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2026.107514_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70019","article-title":"Betulin ameliorates neuronal apoptosis and oxidative injury via DJ-1\/Akt\/Nrf2 signaling pathway after subarachnoid hemorrhage","volume":"30","author":"Lu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"11","key":"10.1016\/j.nbd.2026.107514_bb0315","doi-asserted-by":"crossref","first-page":"13830","DOI":"10.3390\/ijms131113830","article-title":"Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade","volume":"13","author":"Maiese","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107514_bb0320","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2016.11.010","article-title":"Roles of peroxisome proliferator-activated receptor \u03b2\/\u03b4 in skeletal muscle physiology","volume":"136","author":"Manickam","year":"2017","journal-title":"Biochimie"},{"issue":"33","key":"10.1016\/j.nbd.2026.107514_bb0325","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1074\/jbc.RA120.013303","article-title":"Garcinoic acid prevents \u03b2-amyloid (A\u03b2) deposition in the mouse brain","volume":"295","author":"Marinelli","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107514_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1375531","article-title":"Amelioration of experimental autoimmune encephalomyelitis by gemfibrozil in mice via PPAR\u03b2\/\u03b4: implications for multiple sclerosis","volume":"18","author":"Mondal","year":"2024","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0335","doi-asserted-by":"crossref","first-page":"341","DOI":"10.34067\/KID.0006662022","article-title":"PPAR \u03b4 agonism ameliorates renal fibrosis in an Alport syndrome mouse model","volume":"4","author":"Omachi","year":"2023","journal-title":"Kidney360"},{"key":"10.1016\/j.nbd.2026.107514_bb0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2023.08.005","article-title":"PPAR\u03b4 activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction","volume":"183","author":"Palioura","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7059","key":"10.1016\/j.nbd.2026.107514_bb0345","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nature03988","article-title":"A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma","volume":"437","author":"Pascual","year":"2005","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.nbd.2026.107514_bb0350","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/MCB.20.14.5119-5128.2000","article-title":"Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)","volume":"20","author":"Peters","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"21","key":"10.1016\/j.nbd.2026.107514_bb0355","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70948","article-title":"PPARevolution. First PPAR\u03b4 agonist and a dual PPAR\u03b1\/PPAR\u03b4 activator approved for the treatment of primary biliary cholangitis","volume":"29","author":"Popescu","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0360","first-page":"3743","article-title":"Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosis","volume":"8","author":"Qi","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.nbd.2026.107514_bb0365","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2174\/1568026621666210521165532","article-title":"The role of peroxisome proliferator-activated receptor in addiction: a novel drug target","volume":"21","author":"Quiroga","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2026.107514_bb0370","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/jnc.13205","article-title":"Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice","volume":"134","author":"Santhanam","year":"2015","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.nbd.2026.107514_bb0375","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jhep.2021.01.013","article-title":"A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA","volume":"74","author":"Schattenberg","year":"2021","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107514_bb0380","doi-asserted-by":"crossref","first-page":"H1037","DOI":"10.1152\/ajpheart.00677.2004","article-title":"Peroxisome proliferator-activated receptors and cardiovascular remodeling","volume":"288","author":"Schiffrin","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.nbd.2026.107514_bb0385","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.freeradbiomed.2012.02.032","article-title":"PPAR\u03b4 prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-\u03baB and inhibition of the PKC\u03b1\/MEK1\/2\/ERK1\/2\/AP-1 pathway","volume":"52","author":"Schnegg","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2026.107514_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115433","article-title":"Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders","volume":"209","author":"Seminotti","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"14","key":"10.1016\/j.nbd.2026.107514_bb0395","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2174\/1389450122666210224105945","article-title":"Mitochondrial dysfunction in Huntington\u2019s disease: pathogenesis and therapeutic opportunities","volume":"22","author":"Sharma","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.nbd.2026.107514_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114616","article-title":"Potentials of peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\/\u03b4, and \u03b3: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases","volume":"155","author":"Singh","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2026.107514_bb0405","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuropharm.2016.06.009","article-title":"A novel small-molecule agonist of PPAR-\u03b3 potentiates an anti-inflammatory M2 glial phenotype","volume":"109","author":"Song","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.nbd.2026.107514_bb0410","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00024677-200504050-00004","article-title":"A new perspective in the treatment of dyslipidemia: can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?","volume":"4","author":"Steiner","year":"2005","journal-title":"Treat. Endocrinol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12017-020-08629-9","article-title":"Recent insights on the role of PPAR-\u03b2\/\u03b4 in neuroinflammation and neurodegeneration, and its potential target for therapy","volume":"23","author":"Strosznajder","year":"2021","journal-title":"Neuromolecular Med."},{"issue":"22","key":"10.1016\/j.nbd.2026.107514_bb0420","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401530RR","article-title":"Siramesine attenuates early brain injury through the TMEM97\/NPC1 pathway after experimental subarachnoid hemorrhage in rats","volume":"39","author":"Sun","year":"2025","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543776.2020.1703952","article-title":"Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)","volume":"30","author":"Takada","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0430","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/STROKEAHA.115.011701","article-title":"Peroxisome proliferator-activated receptor \u03b2\/\u03b4 alleviates early brain injury after subarachnoid hemorrhage in rats","volume":"47","author":"Teng","year":"2016","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0435","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","article-title":"PPAR agonists for the treatment of neuroinflammatory diseases","volume":"45","author":"Titus","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.nbd.2026.107514_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155296","article-title":"Peroxisome proliferator-activated receptor Beta\/Delta agonist suppresses inflammation and promotes neovascularization","volume":"21","author":"Tobita","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2026.107514_bb0445","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2015.08.025","article-title":"Association of functional genetic variants in PPAR\u03b4 encoding peroxisome proliferator-activated receptor delta with ischemic stroke in Chinese Uyghur population","volume":"358","author":"Tong","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3233\/JAD-151013","article-title":"T3D-959: a multi-faceted disease remedial drug candidate for the treatment of Alzheimer\u2019s disease","volume":"51","author":"Tong","year":"2016","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbd.2026.107514_bb0455","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0460","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12035-025-05514-z","article-title":"Anandamide-induced neuroprotection of cortical neurons relies on metabolic\/redox regulation and mitochondrial dynamics","volume":"63","author":"Torres-Rom\u00e1n","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.nbd.2026.107514_bb0465","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263651","article-title":"NHR-85 modulates mitochondrial and lipid homeostasis to protect against \u03b1-synuclein aggregation in C. elegans","volume":"138","author":"Tsagkari","year":"2025","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.nbd.2026.107514_bb0470","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/ejn.15904","article-title":"Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPAR\u03b4-ligand erucic acid in rotenone-induced Parkinson\u2019s disease model in zebrafish","volume":"57","author":"\u00dcnal","year":"2023","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2026.107514_bb0475","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pep.2009.09.012","article-title":"Ligand-enhanced expression and in-cell assay of human peroxisome proliferator-activated receptor alpha ligand binding domain","volume":"70","author":"Velkov","year":"2010","journal-title":"Protein Expr. Purif."},{"issue":"11","key":"10.1016\/j.nbd.2026.107514_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112367","article-title":"The role of PPARs in disease","volume":"9","author":"Wagner","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2026.107514_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1293164","article-title":"A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer\u2019s disease mouse models through attenuating mitochondrial function","volume":"15","author":"Wang","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2026.107514_bb0490","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12500","article-title":"Peroxisome proliferator-activated receptor \u03b2\/\u03b4 regulates cerebral vasospasm after subarachnoid hemorrhage via modulating vascular smooth muscle cells phenotypic conversion","volume":"24","author":"Xu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.nbd.2026.107514_bb0495","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","article-title":"NLRP3 inflammasome in neuroinflammation and central nervous system diseases","volume":"22","author":"Xu","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.nbd.2026.107514_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168846","article-title":"Decreased peak expiratory flow associated with muscle Fiber-type switching in spinal and bulbar muscular atrophy","volume":"11","author":"Yamada","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.nbd.2026.107514_bb0505","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10143-025-03233-6","article-title":"Research progress of early brain injury in subarachnoid hemorrhage from 2004 to 2024: a bibliometric analysis","volume":"48","author":"Ye","year":"2025","journal-title":"Neurosurg. Rev."},{"issue":"7","key":"10.1016\/j.nbd.2026.107514_bb0510","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10571-018-0608-3","article-title":"Docosahexaenoic acid alleviates oxidative stress-based apoptosis via improving mitochondrial dynamics in early brain injury after subarachnoid hemorrhage","volume":"38","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"18","key":"10.1016\/j.nbd.2026.107514_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810015","article-title":"PPAR\u03b2\/\u03b4 agonist GW0742 modulates microglial and astroglial gene expression in a rat model of temporal lobe epilepsy","volume":"25","author":"Zubareva","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:47:22Z","timestamp":1787582842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":103,"alternative-id":["S0969996126002597"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107514","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b4 in neurological diseases: Mechanisms and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107514"}}